The pharmaceutical company has set a $471m target for an investment unit that will fund healthcare startups.

The programme will focus on hardware startups targeting the consumer health sector, and will invest different amounts dependent on the development stage of each.

Immatics Biotechnologies has teamed up with University of Texas MD Anderson Cancer Center to set up Immatics US and develop treatments for tumours.

Immatics Biotechnologies has teamed up with University of Texas MD Anderson Cancer Center to set up Immatics US and develop treatments for tumours.

Novo, Novartis, Johnson & Johnson and Pfizer have taken part in a series C round for Merus, which was previously reported to be gearing up for an IPO in the US.

The cancer treatment developer has raised $94m in equity and grant funding, with Pfizer, Celgene and Baxter among its shareholders.

Wisconsin-Madison spinout FluGen secures $12m series A for universal influenza vaccine.

Jkom Cloud Health Technology has participated in a series A for DynoSense, the creator of a scanner that analyses health metrics such as blood pressure.